CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-01 | Lehman David Aaron General Counsel | Sale | −679 | $18.05 | $12K | 46,311 |
| 2022-06-01 | Florin Daniel P Director | Grant or award | +5,600 | 13,132 | ||
| 2022-06-01 | Lynch Alissa Hsu Director | Grant or award | +5,600 | 10,210 | ||
| 2022-05-16 | French Glendon E. III President and CEO | Gift | −25,000 | 1,107,517 | ||
| 2022-03-10 | Rose Geoffrey Beran Chief Commercial Officer | Exercise or conversion | +29,427 | $2.10 | $62K | 184,129 |
| 2022-03-10 | Rose Geoffrey Beran Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −29,427 | 18,192 | ||
| 2022-03-01 | Sung Derrick Chief Financial Officer | Sale | −458 | $25.91 | $12K | 224,962 |
| 2022-03-01 | Sung Derrick Chief Financial Officer | Grant or award | +31,000 | 255,962 | ||
| 2022-03-01 | Sung Derrick Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +68,700 | 68,700 | ||
| 2022-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −426 | $25.91 | $11K | 123,702 |
| 2022-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Grant or award | +31,000 | 154,702 | ||
| 2022-03-01 | Rose Geoffrey Beran Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +68,700 | 68,700 | ||
| 2022-03-01 | Lehman David Aaron General Counsel | Sale | −458 | $25.91 | $12K | 16,376 |
| 2022-03-01 | Lehman David Aaron General Counsel | Grant or award | +31,000 | 47,376 | ||
| 2022-03-01 | Lehman David Aaron General Counsel | Grant or award · Employee Stock Option (right to buy) | +68,700 | 68,700 | ||
| 2022-03-01 | French Glendon E. III President and CEO | Sale | −1,132 | $25.91 | $29K | 1,062,817 |
| 2022-03-01 | French Glendon E. III President and CEO | Grant or award | +69,700 | 1,132,517 | ||
| 2022-03-01 | French Glendon E. III President and CEO | Grant or award · Employee Stock Option (right to buy) | +154,600 | 154,600 | ||
| 2022-02-18 | French Glendon E. III President and CEO | Sale | −8,561 | $26.81 | $230K | 1,067,888 |
| 2022-02-18 | French Glendon E. III President and CEO | Sale | −3,939 | $27.13 | $107K | 1,063,949 |
Page 16 of 23 · 450 trades